Clinical Targeted Next-Generation Panel Sequencing Reveals MYC Amplification Is a Poor Prognostic Factor in Osteosarcoma.
暂无分享，去创建一个
M. Ladanyi | B. Crompton | L. Macconaill | A. Cherniack | N. Shukla | A. Zehir | L. Corson | A. Sabnis | J. Nowak | T. Laetsch | L. Spurr | K. Janeway | A. Mauguen | P. Meyers | M. Applebaum | D. Weiser | C. Fong | S. Colace | Yvonne Y. Li | Suzanne J. Forrest | M. Macy | A. Church | D. Doan | AeRang Kim | J. Glade-Bender | N. Lindeman | Abigail Ward | N. Pinto | Luke D Maese | Amanda E Marinoff | Megan Anderson | Liam F. Spurr | Julia L. Glade-Bender